China successfully launches the Haiyang-1D satellite into orbit
Category: #world  By Pankaj Singh  Date: 2020-06-12
  • share
  • Twitter
  • Facebook
  • LinkedIn

China successfully launches the Haiyang-1D satellite into orbit
  • Haiyang-1D is the 6th satellite in the Haiyang series for Ocean observation satellites and was developed by the Chinese Academy of Space technology (CAST).
  • This is the first successful launch for China since January. The notification of successful launch was given by Taiyun launch center in China.

An ocean observation satellite, Haiyang-1D has been launched into space by China. This is the thirteenth orbital launch by the country this year.

This launch operation of Long March 2C, two-stage hypergolic satellite was conducted from the launch center for satellites in Taiyun, North China. Notices for airspace closure were given days before the launch.

The state-run organization for country’s space programs, China Aerospace Science and technology, confirmed the launch success within half an hour of the launch.

Haiyang 1-D weighed 442 kilograms at launch and was based on the CAST2000 satellite model. The Ocean observation satellite includes instruments such as temperature scanner, ultraviolet imager, coastal zone imager with an automatic identification system to monitor vessels.

This satellite will be used for disaster prevention and management, perform environmental surveys and provide useful data on costal resources, areas offshore along the sea and islands.

Haiyang 1-D satellite will together with the Haiyang-1C satellite launched back in 2018 to conduct observations early in the day as well as the afternoon to improve global aquatic coverage of satellites. As per World Meteorological Organization, the equatorial crossing time for Haiyang-1C will be 10:30am in descent with the crossing time of Haiyang-1D being 1pm.

Haiyang-1D is the 6th satellite in the series of Haiyang satellites for ocean observation launched by China in addition to the CFOSAT (China France Oceanography Satellite) launched back in 2018. The Haiyang satellites have all been developed by the Chinese Academy for Space Technology (CAST) which is the biggest space craft manufacturer in China.

This was the first satellite launched from Taiyun since January due to the COVID-19 pandemic. According to statement released in January, CASC is looking to launch 40 satellites as of this year with all plans already in motion. The Satellite launch center in Xichang, China is also preparing to now launch the 55th Beidou positioning and navigation satellite to make the remote sensing system fully operational.

Source Credits: https://spacenews.com/china-launches-haiyang-1d-ocean-observation-satellite/



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
By Pankaj Singh

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19.

...

Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
By Pankaj Singh

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start hum...

Seattle Genetics reveals positive data from tisotumab vedotin trial
Seattle Genetics reveals positive data from tisotumab vedotin trial
By Pankaj Singh

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing ti...